Resultados: 5

    WHO guidelines for the use of thermal ablation for cervical pre-cancer lesions

    The objectives of these guidelines are to provide evidence-based guidance on the use of thermal ablation to treat cervical precancer; and to support countries to update their national guidelines for the use of thermal ablation for cervical precancer....

    Clinical practice guidelines on the screening and treatment of precancerous lesions for cervical cancer prevention in Saudi Arabia

    Ann. Saudi med; 36 (5), 2016
    BACKGROUND: Cervical cancer is the third most common gynecological malignancy in Saudi women with an estimated incidence rate of 1.9 cases per 100 000 women-years. More than 40% of cervical cancer cases are diagnosed at advanced stages due to lack of a routine screening program in Saudi Arabia. Thus, nat...

    Guía de práctica clínica para el diagnóstico, tratamiento y seguimiento del cáncer de piel: queratosis actínica

    Evaluar la efectividad de las medidas preventivas para disminuir la aparición de nuevos casos de queratosis actínicas en la población general. o Evaluar la efectividad y la ocurrencia de eventos adversos asociados a los diferentes tratamientos farmacológicos y nofarmacológicos para el manejo de las ...

    WHO guidelines for treatment of cervical intraepithelial neoplasia 2-3 and adenocarcinoma in situ: cryotherapy, large loop excision of the transformation zone, and cold knife conization

    Cervical intraepithelial neoplasia (CIN) is a premalignant lesion that is diagnosed by histology as CIN1, CIN2, or CIN3. If left untreated, CIN2 or CIN3 (collectively referred to as CIN2+) can progress to cervical cancer. There are three principal treatments for CIN available in low- and middle-income co...

    WHO guidelines Use of cryotherapy for cervical intraepithelial neoplasia

    In 2008, cervical cancer was responsible for 275 000 deaths, of which about 88% occurred in low- and middle-income countries. Cervical cancer is the third most common cancer in women worldwide and the most common cancer in many low- and middle-income countries. Because it has a typically slow progression...